Wall Street Analysts Believe Arcosa (ACA) Could Rally 25.52%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Arcosa (ACA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Top Wind Energy Stocks to Keep an Eye on For Solid Returns
NEE, OGE, POR and ACA are capitalizing on soaring wind energy demand, with strong backlogs and expansion plans boosting growth.
3 Reasons Growth Investors Will Love Arcosa (ACA)
Arcosa (ACA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Does Arcosa (ACA) Have the Potential to Rally 26.49% as Wall Street Analysts Expect?
The mean of analysts' price targets for Arcosa (ACA) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Arcosa, Inc. (ACA) Q1 2025 Earnings Call Transcript
Arcosa, Inc. (NYSE:ACA ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Officer Gail Peck - Chief Financial Officer Conference Call Participants Julio Romero - Sidoti & Company. Brent Thielman - D.A.
Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates
Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago.
New Strong Sell Stocks for May 2nd
ARCB, ACA and BAND have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2025.
CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business
The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.
Is the Options Market Predicting a Spike in Arcosa (ACA) Stock?
Investors need to pay close attention to Arcosa (ACA) stock based on the movements in the options market lately.
New Strong Sell Stocks for April 7th
ASTS, AMPY and ACA have been added to the Zacks Rank #5 (Strong Sell) List on April 7, 2025.
Arcosa Is Poised For A Rebound In 2025 (Rating Upgrade)
ACA's topline grew 14.4% YoY in Q4 2024, driven by strong pricing and recent acquisitions, despite a 14% decline in Transportation Products revenue. Expect continued growth in 2025, fueled by strong infrastructure demand, significant backlogs, and contributions from recent acquisitions like Stavola. ACA is optimizing its portfolio through strategic acquisitions and divestitures, aiming to reduce net leverage from 2.9x to its long-term target of 2-2.5x.
Arcosa, Inc. (ACA) Q4 2024 Earnings Call Transcript
Arcosa, Inc. (NYSE:ACA ) Q4 2024 Earnings Conference Call February 28, 2025 8:30 AM ET Company Participants Erin Drabek - Vice President of Investor Relations Antonio Carrillo - President and CEO Gail Peck - CFO Conference Call Participants Ian Zaffino - Oppenheimer Garik Shmois - Loop Capital Markets Operator Good morning ladies and gentlemen, and welcome to the Arcosa Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Britney, and I will be your conference call coordinator today.
